Edward J. Buthusiem advises executive management and general counsel on a variety of strategic business and operational issues.
A managing director in BRG’s Health Analytics practice, Mr. Buthusiem is an expert in food and drug law, mergers and acquisitions, technology licensing transactions, and innovation.
Since joining BRG in 2013, Mr. Buthusiem has provided expert testimony and support in a number of litigation matters involving, among other things, the interpretation of licensing and development contracts relating to pharmaceutical product development, matters involving fiduciary responsibilities, securities disclosure, adequacy of internal controls and pharmaceutical pre-clinical and clinical development and commercialization.
Mr. Buthusiem leverages his experience as a former senior executive of two major divisions of two multibillion-dollar global life sciences companies, at which he was responsible for all aspects of transactional and legal support, compliance, trade operations, and environmental health and safety.
He has counseled and coordinated responses to foreign and domestic congressional and government investigations, including in the areas of Foreign Corrupt Practices Act, bribery and corruption, antitrust and competition, clinical trials, Food and Drug Administration promotional and manufacturing, and Office of Foreign Assets Control matters. He has also managed intellectual property and commercial litigation, legal, regulatory, and trade compliance, and domestic and international arbitrations, and has provided consulting and testimony on related matters.
Mr. Buthusiem has designed, developed, implemented, and monitored compliance programs and processes to comply with legal obligations (including FCPA and anti-kickback laws), as well as with government-imposed consent decrees. He has also developed and implemented legal department operational efficiencies in contracting, resource allocation, and technology.
Temple University Beasley School of Law
August 2015 – Present
Berkeley Research Group, LLC
January 2013 – Present
Kavo Kerr Group, a Danaher Company
General Counsel, Head of Business Development, Trade Operations and Environmental Health & Safety December 2010 – January 2013
GlaxoSmithKline plc (formerly SmithKline Beecham plc)
October 1990 – December 2010
Senior Vice President and Special Counsel
January 2009 – October 2010
Senior Vice President, General Counsel of Global R&D and Vaccines Divisions, Business Development (Vaccines) and Risk Management
January 2001 – January 2009
Vice President & Associate General Counsel, Strategic & Scientific Transactions Department
January 1995 – January 2001
Senior Counsel, Licensing and Commercial Transactions
October 1990 – December 1995
Dickstein, Shapiro & Morin
January 1987 – October 1990
Fried, Frank, Harris, Shriver & Jacobson
September 1985 – December 1987
Areas of Expertise
University of Pennsylvania
University of Brussels
MBA, International Economics, 1983
Recipient of the Temple University 2003 Diamond Achievement Award
Delivered the 2004 Commencement Speech, Temple University College of Liberal Arts